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In the epithelial-mesenchymal transition of tumors, the loss of cohesivity 
and the migratory capability of cells determine the invasiveness and 
therefore the malignancy of the cancer. Understanding these biophysical 
mechanisms of cancer propagation will help control the disease thereby 
facilitating its treatment. In this study, cohesivity and invasiveness were 
characterized using three-dimensional aggregates constructed from human 
glioblastoma multiforme cells (HB cells). First, we showed that cohesivity 
was affected by the physical environment during incubation. Shear stress, 
simulated microgravity and normal 1g gravity conditions were produced 
respectively by incubation in a gyrotary shaker, in NASA’s High Aspect Ratio 
Vessel (HARV) and in statically kept 24 well-plates. The surface morphology 
of the aggregates observed by field-emission scanning electron microscopy 
became rougher (indicative of a lower intercellular binding) as the forces 
acting upon it were reduced. Interestingly, the effects due to the 
environmental conditions were canceled by addition of an anti-cancer drug: 
dexamethasone (DEX), a corticosteroid often used as an anti-inflammatory 
agent. In a second experiment, the effect of DEX on the invasive pattern of 
HB-cells in three-dimensional collagen matrices was studied. We found that 
DEX slows down cell migration from the aggregate indicating that it modifies 
the interplay between cell-cell adhesion and cell-extracellular matrix 
interaction. One possible mechanism of DEX action is increase in 
intercellular binding due to higher N-cadherin expression, the predominant 
cell-adhesion molecule in brain cells. The quantity of N-cadherin proteins 
was assessed by immunolabelling and flow cytometry after HB cells were 
exposed for 24 hours to various doses of DEX (0 to 10-6M). Preliminary data 
indicate that cells treated with 10-9 to 10-6M DEX express 5 to 60% more N-
cadherin than non treated cells. Further investigations are needed to 
determine the effect of DEX on other factors involved in cell motility such 
as cytoskeleton, integrins, metalloproteinases. Exploring the molecular bases 
that control the bulk physical properties of tumor tissues (modeled here by 
the multicellular aggregates) may create new means to control cancer 
metastasis. 
